List of Tables
Table 1. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Shandong Jingwei Pharmaceutical Co., Ltd. Company Information
Table 71. Shandong Jingwei Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Shandong Jingwei Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Shandong Jingwei Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 74. Shandong Jingwei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Huayi Taikang Pharmaceutical Co., Ltd. Company Information
Table 76. Huayi Taikang Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Huayi Taikang Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Huayi Taikang Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 79. Huayi Taikang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
Table 81. Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Jiangsu Xuantai Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Jiangsu Xuantai Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 84. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
Table 86. Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Beijing Fuyuan Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Beijing Fuyuan Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 89. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Shenzhen Xinlitai Pharmaceutical Co., Ltd. Company Information
Table 91. Shenzhen Xinlitai Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Shenzhen Xinlitai Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Shenzhen Xinlitai Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 94. Shenzhen Xinlitai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. Company Information
Table 96. Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Product
Table 99. Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Distributors List
Table 103. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Customers List
Table 104. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Trends
Table 105. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Drivers
Table 106. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Challenges
Table 107. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets
Figure 2. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Share by Type: 2025 & 2032
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales (K Units), 2021–2032
Figure 14. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Report Years Considered
Figure 16. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Players: Market Share by Revenue in Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets in 2025
Figure 19. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets by Type (2021–2032)
Figure 54. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets by Application (2021–2032)
Figure 57. Global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
